[Current management of left heart failure].
Rothlin
M E
ME
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D009573:Nitrites / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D004232:Diuretics; D009573:Nitrites; D010726:Phosphodiesterase Inhibitors; D006830:Hydralazine; D011224:Prazosin
Moderne Behandlung der Linksherzinsuffizienz.